Sanofi Consumer Healthcare India Limited - ENTEROGERMINA

Recommendation: Upheld | Medium: Suo Motu - NAMS (TAMS)

In the absence of required action on or before the prescribed due date, CCC considered this complaint exparte. Claim, "India’s No.1 PEDIATRICIAN RECOMMENDED PROBIOTIC", was not substantiated with supporting evidence of research conducted amongst pediatricians to prove that the advertiser's product - “Enterogermina” is in leadership position (No.1) as the most recommended probiotic in India. The source and date for the claim is not indicated in the advertisement. The claim is misleading by exaggeration This advertisement is in contravention of Chapter I, Clauses 1.1, 1.2, and 1.4 of the ASCI Code. Complaint was Upheld.